1. Home
  2. GNFT vs FUND Comparison

GNFT vs FUND Comparison

Compare GNFT & FUND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • FUND
  • Stock Information
  • Founded
  • GNFT 1999
  • FUND 1988
  • Country
  • GNFT France
  • FUND Canada
  • Employees
  • GNFT N/A
  • FUND N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • FUND Investment Managers
  • Sector
  • GNFT Health Care
  • FUND Finance
  • Exchange
  • GNFT Nasdaq
  • FUND Nasdaq
  • Market Cap
  • GNFT 249.0M
  • FUND 230.1M
  • IPO Year
  • GNFT 2019
  • FUND N/A
  • Fundamental
  • Price
  • GNFT $5.98
  • FUND $7.71
  • Analyst Decision
  • GNFT Strong Buy
  • FUND
  • Analyst Count
  • GNFT 1
  • FUND 0
  • Target Price
  • GNFT $13.00
  • FUND N/A
  • AVG Volume (30 Days)
  • GNFT 21.1K
  • FUND 32.5K
  • Earning Date
  • GNFT 09-19-2024
  • FUND 01-01-0001
  • Dividend Yield
  • GNFT N/A
  • FUND 6.64%
  • EPS Growth
  • GNFT N/A
  • FUND N/A
  • EPS
  • GNFT 0.47
  • FUND 0.93
  • Revenue
  • GNFT $86,225,222.00
  • FUND N/A
  • Revenue This Year
  • GNFT $155.44
  • FUND N/A
  • Revenue Next Year
  • GNFT N/A
  • FUND N/A
  • P/E Ratio
  • GNFT $11.74
  • FUND $8.33
  • Revenue Growth
  • GNFT 175.45
  • FUND N/A
  • 52 Week Low
  • GNFT $2.97
  • FUND $6.75
  • 52 Week High
  • GNFT $6.05
  • FUND $8.47
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 68.96
  • FUND 51.42
  • Support Level
  • GNFT $5.41
  • FUND $7.65
  • Resistance Level
  • GNFT $5.84
  • FUND $7.72
  • Average True Range (ATR)
  • GNFT 0.30
  • FUND 0.05
  • MACD
  • GNFT 0.03
  • FUND 0.00
  • Stochastic Oscillator
  • GNFT 90.17
  • FUND 55.00

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About FUND Sprott Focus Trust Inc.

Sprott Focus Trust Inc is a diversified closed-end investment company. Its primary investment objective is long-term capital growth. To achieve its objective, The Fund may invest its assets in equity securities and in direct obligations of the U.S. Government or its agencies and in the non-convertible preferred stocks & debt securities of domestic and foreign companies. It invests in various sectors, of which Materials, Financials, Energy, Information technology sector account for the majority weightage.

Share on Social Networks: